September 14, 2016

Biogazelle presents ‘Liquid biopsy RNA biomarkers’ at NLS days in Stockholm

Belgium — September 14, 2016 — Biogazelle’s CEO dr Jan Hellemans will present Biogazelle’s strategy and expertise to deploy RNA in liquid biopsies to further diagnostic applications and drug development at the “Nordic Life Science days 2016” (Stockholm, Sweden). A PDF version of the presentation is available from the Knowledge center on Biogazelle’s website.

March 24, 2016

Nature publishes study on melanoma addiction to the long non-coding RNA SAMMSON, providing solid proof-of-concept for Biogazelle’s lncRNA targeting anti-cancer platform

The 'Survival Associated Mitochondrial Melanoma Specific ONcogenic RNA' is a long non-coding RNA that is specifically expressed in malignant melanoma cells, and not in other normal human cells or other cancer types. Using antisense mediated RNA targeting therapy, Leucci et al. selectively kill melanoma cells in vitro and in vivo xenograft mouse models.

February 10, 2016

Meet us at the Annual Biomarkers Congress 2016

This Biomarker Congress (February 25-26, Manchester, UK) creates the perfect forum to showcase Biogazelle’s RNA biomarker discovery platform. Our platform is designed to unlock the untapped potential of more than 80 000 candidate RNA biomarkers and to define robust biomarker signatures. This platform is driving our own RNA biomarker discovery programs and accelerates that of our customers and partners.

November 5, 2015

Exiqon’s antisense products are best in class in new comparative study

Exiqon A/S (NASDAQ OMX: EXQ), a leading provider of flexible solutions for RNA analysis, today announced the impressive results of a comparative study on technologies for functional knockdown.

The study was conducted by Biogazelle, a Belgium company focusing on nucleic acid-based drug technologies for RNA-targeting therapies in cancer. Within this in vitro study, Exiqon’s Antisense LNA™ GapmeR technology was shown to be superior to other technologies tested for knockdown capability of lncRNAs (long non-coding RNAs).